TN2014000342A1 - New pediatric uses of cabazitaxel - Google Patents
New pediatric uses of cabazitaxelInfo
- Publication number
- TN2014000342A1 TN2014000342A1 TNP2014000342A TN2014000342A TN2014000342A1 TN 2014000342 A1 TN2014000342 A1 TN 2014000342A1 TN P2014000342 A TNP2014000342 A TN P2014000342A TN 2014000342 A TN2014000342 A TN 2014000342A TN 2014000342 A1 TN2014000342 A1 TN 2014000342A1
- Authority
- TN
- Tunisia
- Prior art keywords
- cabazitaxel
- pediatric uses
- new pediatric
- new
- solvate
- Prior art date
Links
- BMQGVNUXMIRLCK-OAGWZNDDSA-N cabazitaxel Chemical compound O([C@H]1[C@@H]2[C@]3(OC(C)=O)CO[C@@H]3C[C@@H]([C@]2(C(=O)[C@H](OC)C2=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=3C=CC=CC=3)C[C@]1(O)C2(C)C)C)OC)C(=O)C1=CC=CC=C1 BMQGVNUXMIRLCK-OAGWZNDDSA-N 0.000 title 1
- 229960001573 cabazitaxel Drugs 0.000 title 1
- 208000011654 childhood malignant neoplasm Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
The present invention relates to the compound of formula (I): which may be in the form of an anhydrous base, a hydrate or a solvate, for its use for the treatment of pediatric cancers.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306352 | 2012-10-30 | ||
| PCT/EP2013/052518 WO2013117683A1 (en) | 2012-02-10 | 2013-02-08 | New pediatric uses of cabazitaxel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2014000342A1 true TN2014000342A1 (en) | 2015-12-21 |
Family
ID=47137643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2014000342A TN2014000342A1 (en) | 2012-10-30 | 2014-08-07 | New pediatric uses of cabazitaxel |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2014000342A1 (en) |
-
2014
- 2014-08-07 TN TNP2014000342A patent/TN2014000342A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017502141A1 (en) | Compounds and their methods of use | |
| PH12014502169A1 (en) | N-cyclylamides as nematicides | |
| IN2015DN01156A (en) | ||
| NZ700928A (en) | Dna-pk inhibitors | |
| IN2014DN09346A (en) | ||
| MX2015002040A (en) | Deuterated baricitinib. | |
| IN2015DN00598A (en) | ||
| MX2015007097A (en) | Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer. | |
| MX2014012477A (en) | Pyrrolopyrazone inhibitors of tankyrase. | |
| PH12015501088A1 (en) | Dimeric compounds | |
| GEP201706690B (en) | Novel process for making compounds for use in treatment of cancer | |
| GEP201706626B (en) | Synthesis of (s)-nifuratel | |
| TN2012000469A1 (en) | Use of novel pan-cdk inhibitors for treating tumors | |
| MX2016001641A (en) | Cyclobutyl carboxamides as nematicides. | |
| NZ720106A (en) | A process for the preparation of regadenoson | |
| PH12015500399A1 (en) | Azaindolines | |
| MX2015014470A (en) | Combretastatin analogs. | |
| MX365192B (en) | Bendamustine derivatives and related compounds, and medical use thereof cancer therapy. | |
| MX2016000487A (en) | Pyridine-2-carboxamides as nematocides. | |
| EA033160B1 (en) | Compounds for the treatment of ischemia-reperfusion- related diseases | |
| MX2017014463A (en) | Cabazitaxel and its use for treating cancer. | |
| PH12015502703A1 (en) | Pharmaceutical compositions | |
| PH12014501794A1 (en) | New pediatric uses of cabazitaxel | |
| TN2014000342A1 (en) | New pediatric uses of cabazitaxel | |
| MX2015009377A (en) | Radiolabeled compounds. |